You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

meso-zeaxanthin

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle Trial in Dublin (10 mg Lutein, 2 mg zeaxanthin, 10 mg meso-zeaxanthin, Placebo)

Completed
  • Glaucoma, Open-Angle
  • 10 mg Lutein, 2 mg zeaxanthin, 10 mg meso-zeaxanthin
  • Placebo
  • Dublin, Co. Dublin, Ireland
    Centre for Eye Research Ireland
Aug 5, 2021

Constrast Sensitivity Trial (Carotenoids supplementation, Placebo)

Not yet recruiting
  • Constrast Sensitivity
  • Carotenoids supplementation
  • Placebo
  • (no location specified)
Oct 19, 2023

Age Related Macular Degeneration Trial in Bern (NUTROF TOTAL)

Completed
  • Age Related Macular Degeneration
  • NUTROF TOTAL
  • Bern, Switzerland
    Department of Ophthalmology, Inselspital, Bern University Hostpi
Jan 24, 2023

Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial in San Antonio (dietary supplement, drug, other)

Withdrawn
  • Glaucoma
  • +2 more
  • Lumega-Z
  • +2 more
  • San Antonio, Texas
    Ophtalmology Clinic of William E Sponsel
Sep 30, 2022

Association of MPOD Values With Blue Light.

Recruiting
  • Age Related Macular Degeneration
    • Saint Lucia, Queensland, Australia
      School of Human Movement and Nutrition Sciences, The University
    Mar 3, 2021

    Macula Lutea Opacity Trial in Saint Lucia (Lutein supplement, Food, blended, Food, unprocessed)

    Withdrawn
    • Macula Lutea Opacity
    • Lutein supplement
    • +2 more
    • Saint Lucia, Queensland, Australia
      School of Human Movement and Nutrition Sciences, The University
    Jul 6, 2021

    Dietary Intake Food Frequency Questionnaire Over Four Weeks, and

    Recruiting
    • Lutein and Zeaxanthin Dietary Intake
    • +3 more
    • Weekly Food Frequency Questionnaire
    • +4 more
    • St Lucia, Queensland, Australia
      University of Queensland
    Mar 3, 2021

    Wenzhou Dry Age-related Macular Degeneration Progression Study

    Recruiting
    • Macular Pigment Optical Density
      • Wenzhou, Zhejiang, China
        The eye hospital of Wenzhou Medical University
      Feb 23, 2021

      Lung Adenocarcinoma, Ovarian Cancer, Peritoneal Carcinoma Trial in Philadelphia (huCART-meso cells)

      Recruiting
      • Lung Adenocarcinoma
      • +5 more
      • huCART-meso cells
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 1, 2022

      Diabetic Foot Ulcers (DFUs) Trial in Pembroke Pines, Ford City, Pittsburgh (Meso Wound Matrix)

      Active, not recruiting
      • Diabetic Foot Ulcers (DFUs)
      • Meso Wound Matrix
      • Pembroke Pines, Florida
      • +2 more
      Nov 3, 2022

      Pancreatic Cancer, Cancer of the Pancreas Trial in Philadelphia (huCART-meso cells)

      Recruiting
      • Pancreatic Cancer
      • Cancer of the Pancreas
      • huCART-meso cells
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Dec 9, 2022

      Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food Trial (luteine and zeaxanthine, luteine, zeaxanthine)

      Not yet recruiting
      • Nutrition Deficiency (Xanth Deficiency) Due to A Particular Kind of Food
      • luteine and zeaxanthine
      • +3 more
      • (no location specified)
      Mar 20, 2023

      Cancer Metastatic, Metastatic Solid Tumor Trial (Zeaxanthin, Zeaxanthin Plus Pembrolizumab)

      Not yet recruiting
      • Cancer Metastatic
      • Metastatic Solid Tumor
      • Zeaxanthin
      • Zeaxanthin Plus Pembrolizumab
      • (no location specified)
      Feb 8, 2022

      Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)

      Recruiting
      • Macular Degeneration
      • +3 more
      • Pistachio Group
      • Boston, Massachusetts
        Clinical and Translational Research Center (CTRC) - Tufts
      Jun 9, 2022

      Coronary Artery Disease, Diabetes, Metabolic Syndrome Trial in Storrs (Consume 2 eggs with spinach per day, Egg Subsitute with

      Completed
      • Coronary Artery Disease
      • +2 more
      • Consume 2 eggs with spinach per day
      • Egg Subsitute with spinach per day
      • Storrs, Connecticut
        Department of Nutritional Sciences
      Nov 1, 2022

      Pancreatic Cancer, Serous Ovarian Cancer Trial in Philadelphia (VCN-01, huCART-meso Cells)

      Recruiting
      • Pancreatic Cancer
      • Serous Ovarian Cancer
      • VCN-01
      • huCART-meso Cells
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Feb 17, 2022

      Pleural Mesothelioma Malignant Advanced Trial in Worldwide (Carboplatin, Pemetrexed, Bevacizumab)

      Active, not recruiting
      • Pleural Mesothelioma Malignant Advanced
      • Leuven, Belgium
      • +41 more
      Aug 23, 2022

      Previously Unresectable Malignant Pleural Mesothelioma Treated

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Unresectable Malignant Neoplasm
      • Data collection
      • Brest, France
      • +4 more
      Mar 30, 2022

      Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

      Not yet recruiting
      • Solid Tumor, Adult
      • +19 more
      • A2B694
      • xT CDx with HLA-LOH Assay
      • Duarte, California
      • +9 more
      Sep 22, 2023

      Eye Health, Vision, Cognitive Function Trial in Lutz, Tampa (VisionPure Dietary Supplement, Placebo)

      Recruiting
      • Eye Health
      • +2 more
      • VisionPure Dietary Supplement
      • Placebo
      • Lutz, Florida
      • +2 more
      Sep 6, 2022

      Ovarian Cancer Trial in Shanghai (anti- MESO CAR-T cells, Fludarabine, Cyclophosphamide)

      Recruiting
      • Ovarian Cancer
      • anti- MESO CAR-T cells
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai 6th People's Hospital
      Aug 9, 2021

      Refractory Malignant Solid Tumor Trial in Shanghai (anti-MESO CAR T cells)

      Recruiting
      • Refractory Malignant Solid Neoplasm
      • anti-MESO CAR T cells
      • Shanghai, China
        Department of Oncology, Ruijin Hospital
      Sep 16, 2021

      Hypercholesterolemia, Hyperlipidemias, Physical Inactivity Trial in Adelaide (Egg diet, Egg-free Diet, Control Diet)

      Recruiting
      • Hypercholesterolemia
      • +3 more
      • Egg diet
      • +2 more
      • Adelaide, South Australia, Australia
        University of South Australia Clinical Trial Facility
      Mar 1, 2022

      Pancreatic Cancer Trial in Nanjing (CART-meso cells)

      Unknown status
      • Pancreatic Cancer
      • CART-meso cells
      • Nanjing, Jiangsu, China
        Nanjing First Hospital
      Feb 3, 2021

      Alcohol Withdrawal Trial in Paris (Active rTMS, Sham rTMS)

      Not yet recruiting
      • Alcohol Withdrawal
      • Active rTMS
      • Sham rTMS
      • Paris, France
        Hôpital Universitaire Pitié-Salpêtrière
      Aug 27, 2021